Biblio

Export 676 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is Z  [Clear All Filters]
2016
P. R. Spilman, Corset, V., Gorostiza, O., Poksay, K. S., Galvan, V., Zhang, J., Rao, R., Peters-Libeu, C., Vincelette, J., McGeehan, A., Dvorak-Ewell, M., Beyer, J., Campagna, J., Bankiewicz, K., Mehlen, P., John, V., and Bredesen, D. E., “Netrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 223-42, 2016.
X. Zhou, Huang, J., Pan, S., Xu, M., He, R., Ji, Z., and Hu, Y., “Neurodegeneration-Like Pathological and Behavioral Changes in an AAV9-Mediated p25 Overexpression Mouse Model.”, J Alzheimers Dis, vol. 53, no. 3, pp. 843-55, 2016.
M. Fà, Zhang, H., Staniszewski, A., Saeed, F., Shen, L. W., Schiefer, I. T., Siklos, M. I., Tapadar, S., Litosh, V. A., Libien, J., Petukhov, P. A., Teich, A. F., Thatcher, G. R. J., and Arancio, O., “Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 707-21, 2016.
C. Sassi, Capozzo, R., Gibbs, R., Crews, C., Zecca, C., Arcuti, S., Copetti, M., Barulli, M. R., Brescia, V., Singleton, A. B., and Logroscino, G., “A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.”, J Alzheimers Dis, vol. 53, no. 2, pp. 475-85, 2016.
Y. Deng, Wei, J., Cheng, J., Zhong, P., Xiong, Z., Liu, A., Lin, L., Chen, S., and Yan, Z., “Partial Amelioration of Synaptic and Cognitive Deficits by Inhibiting Cofilin Dephosphorylation in an Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1419-32, 2016.
Y. Xing, Tang, Y., Zhao, L., Wang, Q., Qin, W., Zhang, J. - L., and Jia, J., “Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1029-35, 2016.
Y. Xing, Tang, Y., Zhao, L., Wang, Q., Qin, W., Zhang, J. - L., and Jia, J., “Plasma Ceramides and Neuropsychiatric Symptoms of Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 3, pp. 1029-35, 2016.
L. Xu, Wu, X., Li, R., Chen, K., Long, Z., Zhang, J., Guo, X., and Yao, L., “Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1045-56, 2016.
R. A. Stern, Tripodis, Y., Baugh, C. M., Fritts, N. G., Martin, B. M., Chaisson, C., Cantu, R. C., Joyce, J. A., Shah, S., Ikezu, T., Zhang, J., Gercel-Taylor, C., and Taylor, D. D., “Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1099-109, 2016.
H. - D. Tang, Zhou, Y., Gao, X., Liang, L., Hou, M. - M., Qiao, Y., Ma, J. - F., and Di Chen, S. -, “Prevalence and Risk Factor of Cognitive Impairment were Different between Urban and Rural Population: A Community-Based Study.”, J Alzheimers Dis, vol. 49, no. 4, pp. 917-25, 2016.
X. - P. Hong, Chen, T., Yin, N. - N., Han, Y. - M., Yuan, F., Duan, Y. - J., Shen, F., Zhang, Y. - H., and Bin Chen, Z. -, “Puerarin Ameliorates D-Galactose Induced Enhanced Hippocampal Neurogenesis and Tau Hyperphosphorylation in Rat Brain.”, J Alzheimers Dis, vol. 51, no. 2, pp. 605-17, 2016.
L. D. Estrada, Chamorro, D., Yañez, M. José, Gonzalez, M., Leal, N., von Bernhardi, R., Dulcey, A. E., Marugan, J., Ferrer, M., Soto, C., Zanlungo, S., Inestrosa, N. C., and Alvarez, A. R., “Reduction of Blood Amyloid-β Oligomers in Alzheimer's Disease Transgenic Mice by c-Abl Kinase Inhibition.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1193-1205, 2016.
F. - D. Li, He, F., Chen, T. - R., Xiao, Y. - Y., Lin, S. - T., Shen, W., Wang, X. - Y., Zhai, Y. - J., Shang, X. - P., and Lin, J. - F., “Reproductive history and risk of cognitive impairment in elderly women: a cross-sectional study in eastern China.”, J Alzheimers Dis, vol. 49, no. 1, pp. 139-47, 2016.
L. Szalárdy, Zádori, D., Klivenyi, P., and Vecsei, L., “The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis.”, J Alzheimers Dis, vol. 53, no. 2, pp. 373-92, 2016.
M. A. Beydoun, Canas, J. - A., Dore, G. A., Beydoun, H. A., Rostant, O. S., Fanelli-Kuczmarski, M. T., Evans, M. K., and Zonderman, A. B., “Serum Uric Acid and Its Association with Longitudinal Cognitive Change Among Urban Adults.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1415-30, 2016.
Q. Ye, Bai, F., and Zhang, Z., “Shared Genetic Risk Factors for Late-Life Depression and Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 1-15, 2016.
E. Portelius, Durieu, E., Bodin, M., Cam, M., Pannee, J., Leuxe, C., Mabondzo, A., Oumata, N., Galons, H., Lee, J. Yeol, Chang, Y. - T., Stϋber, K., Koch, P., Fontaine, G., Potier, M. - C., Manousopoulou, A., Garbis, S. D., Covaci, A., Van Dam, D., De Deyn, P., Karg, F., Flajolet, M., Omori, C., Hata, S., Suzuki, T., Blennow, K., Zetterberg, H., and Meijer, L., “Specific Triazine Herbicides Induce Amyloid-β42 Production.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1593-1605, 2016.
G. Chen, Shu, H., Chen, G., B Ward, D., Antuono, P. G., Zhang, Z., and Li, S. - J., “Staging Alzheimer's Disease Risk by Sequencing Brain Function and Structure, Cerebrospinal Fluid, and Cognition Biomarkers.”, J Alzheimers Dis, vol. 54, no. 3, pp. 983-993, 2016.
A. Karch, Llorens, F., Schmitz, M., Arora, A. Singh, Zafar, S., Lange, P., Schmidt, C., and Zerr, I., “Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1385-1393, 2016.
A. Karch, Llorens, F., Schmitz, M., Arora, A. Singh, Zafar, S., Lange, P., Schmidt, C., and Zerr, I., “Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1385-1393, 2016.
D. Li, Huang, Y., Cheng, B., Su, J., Zhou, W. - X., and Zhang, Y. - X., “Streptozotocin Induces Mild Cognitive Impairment at Appropriate Doses in Mice as Determined by Long-Term Potentiation and the Morris Water Maze.”, J Alzheimers Dis, vol. 54, no. 1, pp. 89-98, 2016.
D. Li, Huang, Y., Cheng, B., Su, J., Zhou, W. - X., and Zhang, Y. - X., “Streptozotocin Induces Mild Cognitive Impairment at Appropriate Doses in Mice as Determined by Long-Term Potentiation and the Morris Water Maze.”, J Alzheimers Dis, vol. 54, no. 1, pp. 89-98, 2016.
J. Shang, Yamashita, T., Zhai, Y., Nakano, Y., Morihara, R., Fukui, Y., Hishikawa, N., Ohta, Y., and Abe, K., “Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer's Disease Model Mouse.”, J Alzheimers Dis, vol. 52, no. 1, pp. 113-26, 2016.
N. E. Gray, Zweig, J. A., Kawamoto, C., Quinn, J. F., and Copenhaver, P. F., “STX, a Novel Membrane Estrogen Receptor Ligand, Protects Against Amyloid-β Toxicity.”, J Alzheimers Dis, vol. 51, no. 2, pp. 391-403, 2016.
M. D. Zwan, Villemagne, V. L., Doré, V., Buckley, R., Bourgeat, P., Veljanoski, R., Salvado, O., Williams, R., Margison, L., Rembach, A., S Macaulay, L., Martins, R., Ames, D., van der Flier, W. M., Ellis, K. A., Scheltens, P., Masters, C. L., and Rowe, C. C., “Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1115-22, 2016.

Pages